# Pervasis Therapeutics Inc — Form D

Pervasis Therapeutics Inc of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2009-09-15. The offering totals $17.4M, of which $10.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2009-09-15
- Form: D
- Accession: 0001309869-09-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $17.4M
- Amount sold: $10.0M
- Remaining: $7.4M
- Investors: 18
- Date of first sale: 2009-08-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-71452

## Issuer

- Name: Pervasis Therapeutics Inc
- CIK: 0001309869
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: ONE KENDALL SQUARE, SUITE B6101, CAMBRIDGE, MA, 02139-1663
- Phone: 617-621-3407

## Officers, directors & promoters (12)

| Name | Role | Location |
| --- | --- | --- |
| Frederic Chereau | Director | Cambridge, MA |
| Earl M Collier | Director | Cambridge, MA |
| Elazer R Edelman | Director | Cambridge, MA |
| Robert F Higgins | Director | Cambridge, MA |
| Peter B Hutt | Director | Cambridge, MA |
| Edwin M Kania | Director | Cambridge, MA |
| Robert S Langer | Director | Newton, MA |
| Frank Litvack | Director | MENLO PARK, CA |
| AMIR NASHAT | Director | San Diego, CA |
| Yoram Richter | Director | Cambridge, MA |
| Frederic Chereau | Executive Officer | Cambridge, MA |
| Helen M Nugent | Executive Officer | Cambridge, MA |

## More

- [CIK 1309869 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1309869&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001309869-09-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.